跳至主要内容
临床试验/ACTRN12605000756628
ACTRN12605000756628已完成2 期

A phase II randomised controlled trial in patients on statin therapy who develop sepsis to evaluate the effect of continued atorvastatin use on the incidence of severe sepsis

Dr Peter Kruger, Intensive Care Specialist, Princess Alexandra Hospital, Brisbane0 个研究点目标入组 200 人开始时间: 2005年11月18日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • All patients with sepsis syndrome who are on statin therapy at the time of admisison to hospital are eligable for inclusion.

排除标准

  • Pregnancy, acute liver failure or chronic liver disease ( more than Childs B), patients who are moribund and not expected to survive 24 hrs, patients with rhabdomyolysis or myopathy of any cause. Patients in whom any enteral intake will clearly not be possible within 72 hours.

研究者

发起方
Dr Peter Kruger, Intensive Care Specialist, Princess Alexandra Hospital, Brisbane

相似试验